Life Science Leader — April 2013 Outsourcing and the oral solid dose: Will challenges lead to new patterns of outsourcing? Life Science Leader — CRO Leadership Awards supplement issue Strategic Outsourcing Often Means Combining Functional and Full-Service CROs 
 
May 10 Life Science Leader's May issue includes results from Nice Insight annual research April 10 Learn about Trends in Outsourcing the Oral Solid Dose in April's Outsourcing Insights 
"In the past, if you wanted this type of information, you hired a
third-party agency to survey your customers. Not only did you pay a third
party to collect the data, but you wondered how good was it really? Even
though you hired an outside company, customers filling out the survey still
knew who was sponsoring the research."
PAUL SIDHU VP OF MARKETING AND STRATEGY FOR DSM  
DIA 2013 49th Annual Meeting
June 23-27 Boston, MA |
Catalent Pharma Solutions, Inc. Cirrus Pharmaceuticals DSM Pharmaceutical Products Irvine Pharmaceutical Services, Inc. Patheon Inc. Recipharm AB Therapure Biopharma, Inc.
Integrity Bio, Inc. offers formulation development services as well as designing and constructing GMP compliant parenteral manufacturing facilities. The company has capabilities in the area of formulation development, including preformulation characterization, clinical/commercial formulation development, high concentration antibody formulations, stability studies, lyophilization cycle development, and contract services. It also provides GMP manufacturing services including aseptic filling/capping, lyophilization, testing, and stability programs.
http://
Regions
Stock Symbol Private Filter of 's services per Nice Insight Categories
Contact 
|
|
|
